Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario by Rohini D. Naipaul, Rebecca E. Mercer, Kelvin K. W. Chan, Lyndee Yeung, Leta Forbes, Scott Gavura

Get full text

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer by Caroline Muñoz, Xiaochen Tai, Jessica Arias, Andrea Eisen, Munaza Chaudhry, Scott Gavura, Kelvin K. W. Chan

Get full text

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada by Wei Fang Dai, Jaclyn M. Beca, Ruth Croxford, Wanrudee Isaranawatchai, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Timothy P. Hanna, Kelvin K.W. Chan

Get full text

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies i... by Reka E. Pataky, Jaclyn Beca, David Tran, Wei Fang Dai, Erind Dvorani, Wanrudee Isaranuwatchai, Stuart Peacock, Riaz Alvi, Winson Y. Cheung, Craig C. Earle, Scott Gavura, Kelvin K. W. Chan

Get full text

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization by Brandon Lu, Wei Fang Dai, Ruth Croxford, Wanrudee Isaranuwatchai, Jaclyn Beca, Ines B. Menjak, Teresa M. Petrella, Nicole Mittmann, Craig C. Earle, Scott Gavura, Rebecca E. Mercer, Timothy P. Hanna, Kelvin K. W. Chan

Get full text

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis by Kelvin K. W. Chan, Helen Guo, Sierra Cheng, Jaclyn M. Beca, Ruby Redmond‐Misner, Wanrudee Isaranuwatchai, Lucy Qiao, Craig Earle, Scott R. Berry, James J. Biagi, Stephen Welch, Brandon M. Meyers, Nicole Mittmann, Natalie Coburn, Jessica Arias, Deborah Schwartz, Wei F. Dai, Scott Gavura, Robin McLeod, Erin D. Kennedy

Get full text

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue... by Ambica Parmar, Wei Fang Dai, Francois Dionne, Marc Geirnaert, Avram Denburg, Tarry Ahuja, Jaclyn Beca, Sylvie Bouchard, Carole Chambers, Melissa J. Hunt, Don Husereau, Elena Lungu, Valerie McDonald, Rebecca E. Mercer, Gunita Mitera, Caroline Muñoz, Rohini Naipaul, Stuart Peacock, Tanya Potashnik, Mina Tadrous, Pam Takhar, Marianne Taylor, Maureen Trudeau, Danica Wasney, Scott Gavura, Kelvin K. W. Chan

Get full text